GO
Loading...

Depressed Pooch? Eli Lilly Gets FDA Approval for New Drug

Is your dog depressed? Having trouble letting you go in the morning? Help is on the way.

Eli Lilly said Wednesday it has received approval to market a chewable tablet that calms down dogs who misbehave when separated from their owners.

The Food and Drug Administration has approved Lilly's drug Reconcile to treat the estimated 10.7 million, or 17%, of U.S. dogs that have separation anxiety. According to a company release, dogs that exhibit separation anxiety are prone to "destruction, excess vocalization and inappropriate elimination."

Reconcile is part of a class of antidepressants known as selective serotonin reuptake inhibitors frequently marketed to humans. Lilly's blockbuster depression drug Prozac is one member of the class.

According to Lilly, 73% of dogs treated with the Reconcile showed improved behavior when separated from their owners compared with dogs receiving training alone.

Contact U.S. News

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    › Learn More

Don't Miss

U.S. Video

  • Mad Money's Jim Cramer breaks down the theme of stealth technology stocks. Cramer says companies that are using proprietary technology to invent entirely new markets and then dominate those markets, fall under that category.

  • Mad Money host Jim Cramer knows it can be difficult to stick with a stock that is going lower but says if you've done the homework, and the story isn't wildly off the rails, then stay long.

  • Mad Money host Jim Cramer, outlines the most common emotionally driven investor mistakes and expresses why it is important to not let skepticism run away with you.